Neuropsychiatric debut as a presentation of Guillain-Barré Syndrome: An atypical clinical case and literature review

2017 ◽  
Vol 44 ◽  
pp. 245-249 ◽  
Author(s):  
Dinesh Sangroula ◽  
Richard Durrance ◽  
Shirshak Bhattarai ◽  
Thambirajah Nandakumar
2019 ◽  
Vol 12 (3) ◽  
pp. 243-246 ◽  
Author(s):  
Kentaro Tominaga ◽  
Atsunori Tsuchiya ◽  
Hiroki Sato ◽  
Atsushi Kimura ◽  
Chiyumi Oda ◽  
...  

Author(s):  
Edoardo Agosti ◽  
Andrea Giorgianni ◽  
Francesco D’Amore ◽  
Gabriele Vinacci ◽  
Sergio Balbi ◽  
...  

2021 ◽  
Author(s):  
Mohamad Ali Hussein ◽  
Bruna Pereira Correia ◽  
Leonardo Valente de Camargo ◽  
Vinicius Aldo Cury ◽  
Juliana Passos ◽  
...  

Context: Guillain-Barré syndrome is a polyradiculoneuropathy of heterogeneous manifestations, necessarily presenting progressive appendicular weakness of variable intensity associated with reduction or abolition of deep reflexes. One of its variants is known as Miller Fisher Syndrome (MFS), characterized by ophthalmoparesis, ataxy and areflexia. It usually has, by etiology, immunomediated reactions induced by acute infections, including HIV. Objectives: This report aims to describe a case of MFS with concomitants HIV infection, attended in a tertiary hospital in northern Paraná and compared it with the literature. [1,7] Case report: A 27-year-old white male patient who presented binocular diplopia, dysarthria, dysphagia, generalized hypotonia, myasfasciculations, sensory ataxia and arreflexia, with a score on the Medical Research Council (MRC) muscle strength scale of 54 points. Treatment with empirical intravenous human immunoglobulina ( IVIG ) was performed pending the result of serologies for etiological screening. He was discharged after eleven days of hospitalization with partial symptomatic improvement and results indicative of acute HIV infection. We compared this case with those described in the published literature Discussion: We compared this case with those described in the published literature and given the low incidence found in the literature of patients with the stage of HIV viremia and the opening of the picture of SMF, the concrete pathophysiology itself is still unknown. The mechanism, however, in which the literature proposes in two theories: (1) an autoimmune action against myelin due to abnormal immunoregulation by HIV; (2) direct action of neurotropic strains of HIV-1. [2.3] Our literature review shows that since 1995, cases of associated guillain barré syndrome have already been reported in the course of HIV viremia. Treatment with immunoglobulin at a dose of 400mg / kg / day for 5 days was done and the symptoms improved. [1,4,6,7] Conclusion: It is exposed, then, a case of HIV-induced MFS whose relationship has consistency, temporality, biological plausibility, coherence and analogy compatible with current literature.


Author(s):  
Rahmathulla S. Rahman ◽  
Moayyad S. Bauthman ◽  
Amer M. Alanazi ◽  
Naif N. Alsillah ◽  
Ziyad M. Alanazi ◽  
...  

Guillain–Barré syndrome (GBS) is a polyradiculoneuropathy autoimmune disease that is characterized by significant inflammation that affects the peripheral nervous system in a rapidly progressive pattern that is mainly clinically presented by muscle weakness. The present literature review aims to broadly discuss GBS: etiology, pathophysiology and management in order to gain an understading of the existing studies that are relevant to this literature review. Among the reported antibodies, anti-GM1 and anti-GQ1B have been reported to be responsible for attacking and damaging either the neuromuscular junctions or peripheral nerves. Moreover, it has been found that the anti-GD1a antibodies in patients bind to the neuromuscular junction and also bind to the nodes of Ranvier of the peripheral nerves and the paranodal myelin of the affected nerves. Reports have shown that this disease is identified as special forms of neuropathies that develop in immune-mediated, post-infection sequelae. Furthermore, in another study it was reported that Molecular mimicry has been previously reported to significantly correlate with the development of the disease as it was investigated in animal models. In addition, Campylobacter jejuni, a pathogen that causes gastrointestinal infections has been previously reported to predispose to the development of GBS in humans. However, scientists have found that plasma exchange and intravenous immunoglobulins (IVIG) remain the most significant and efficacious factors in managing the disease. Nevertheless, recent trials have investigated other approaches that are less efficacious and can lead to serious adverse events and complications. 


2018 ◽  
Vol 58 (9) ◽  
pp. 574-577
Author(s):  
Akiko Saito ◽  
Mineki Saito ◽  
Yutaka Shimoe ◽  
Takeshi Yoshimoto ◽  
Mari Kawakami ◽  
...  

BMC Neurology ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Li Ding ◽  
Zhongjun Chen ◽  
Yan Sun ◽  
Haiping Bao ◽  
Xiao Wu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document